What are you working on? Simon Helleputte

What are you working on? Simon Helleputte

What are you working on? Simon Helleputte is a PhD student at Ghent University. His research focuses on cardiovascular health in Type 1 Diabetes. Click here for more information: http://orcid.org/0000-0003-3281-1679 or https://www.researchgate.net/project/Glycemic-control-variability-arterial-stiffness-exercise-capacity-and-cardiovascular-disease-in-type-1-diabetes-and-its-modulation-by-high-intensity-interval-exercise-training

Rosa Maria Bruno flying the flag for VascAgeNet and vascular ageing

Rosa Maria Bruno flying the flag for VascAgeNet and vascular ageing

Rosa Maria Bruno, WG4 leader and one of the initiators of VascAgeNet, flying the flag for @VascAgeNet and #vascularageing. Rosa Maria participated in a webinar on “COVID-19 and the cardiovascular system from basic mechanisms to clinical perspectives” organized by the Turkish Pharmacological Society and European Council for Cardiovascular Research. A recoding of the excellent webinar can be found here: https://youtu.be/qLq6JuFHDsY

Merry Xmas!

Merry Xmas!

Der colleagues, dear friends, dear all, 2020 has been a challenging and extraordinary year! Despite all these challenges in our private and professional life, we as the VascAgeNet have made very good progress – thus, we want to thank you all for your contributions, the great discussions and especially your commitment! We are looking forward to continuing this great work and especially to meet – hopefully soon – face-to-face again!

Read More

VascAgeNet supports CARTESIAN: please donate!

VascAgeNet supports CARTESIAN: please donate!

@VascAgeNet is proud to collaborate with @ArterySociety for the #CARTESIAN study. Donate to this important #COVID19 research here: http://arterysociety.org #longcovid #research #donate DONATE NOW: COVID-19 can severely affect the blood vessels, leading to death or life-threatening complications. The global #CARTESIAN study is investigating the medium and long-term vascular damage of #COVID19.